← Back to Search

Vitamin/Mineral Supplement

ANRC Essentials Plus for Autism Spectrum Disorder

N/A
Waitlist Available
Led By James B Adams, PhD
Research Sponsored by Arizona State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at the 3 months (end of treatment)
Awards & highlights
No Placebo-Only Group

Summary

This trial involves giving children with autism a vitamin and mineral supplement for a period of time. The goal is to see if this supplement can help improve their symptoms. Typically-developing children will also be checked at the start but will not receive the treatment.

Eligible Conditions
  • Autism Spectrum Disorder
  • Autism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at the 3 months (end of treatment)
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at the 3 months (end of treatment) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Parent Global Impressions of Autism

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment GroupExperimental Treatment1 Intervention
This group receives the vitamin/mineral supplement, ANRC Essentials Plus, for 3 months
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ANRC Essentials Plus
2021
N/A
~30

Find a Location

Who is running the clinical trial?

Arizona State UniversityLead Sponsor
298 Previous Clinical Trials
107,907 Total Patients Enrolled
9 Trials studying Autism Spectrum Disorder
733 Patients Enrolled for Autism Spectrum Disorder
Southwest College of Naturopathic MedicineOTHER
5 Previous Clinical Trials
355 Total Patients Enrolled
James B Adams, PhDPrincipal InvestigatorArizona State University
4 Previous Clinical Trials
164 Total Patients Enrolled
3 Trials studying Autism Spectrum Disorder
123 Patients Enrolled for Autism Spectrum Disorder
~7 spots leftby Nov 2025